154 related articles for article (PubMed ID: 38280664)
1. Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope.
Masiyiwa T; Bockarie MJ
Int J Infect Dis; 2024 Mar; 140():102-103. PubMed ID: 38280664
[No Abstract] [Full Text] [Related]
2. Global programme to eliminate lymphatic filariasis: progress report, 2016.
Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
[No Abstract] [Full Text] [Related]
3. Scientists celebrate successes, new tools in fight against human parasitic worms.
Kuehn BM
JAMA; 2013 Jul; 310(1):19-20. PubMed ID: 23821071
[No Abstract] [Full Text] [Related]
4. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Fischer PU; King CL; Jacobson JA; Weil GJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
[No Abstract] [Full Text] [Related]
5. Coverage of preventive measures and surveillance for neglected tropical diseases in hard-to-reach communities in Ghana.
Forson AO; Awuah RB; Mohammed AR; Owusu-Asenso CM; Akosah-Brempong G; Abdulai A; Sraku IK; Dhikrullahi SB; Atakora SB; Attah SK; Afrane YA
BMC Public Health; 2023 Sep; 23(1):1784. PubMed ID: 37710219
[TBL] [Abstract][Full Text] [Related]
6. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
Evans DS; Unnasch TR; Richards FO
Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
[No Abstract] [Full Text] [Related]
7. Anti-
Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H
Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523
[TBL] [Abstract][Full Text] [Related]
8. Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.
Bailey TC; Merritt MW; Tediosi F
Am J Public Health; 2015 Apr; 105(4):629-36. PubMed ID: 25713967
[TBL] [Abstract][Full Text] [Related]
9. Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots.
Njepuome NA; Hopkins DR; Richards FO; Anagbogu IN; Pearce PO; Jibril MM; Okoronkwo C; Sofola OT; Withers PC; Ruiz-Tiben E; Miri ES; Eigege A; Emukah EC; Nwobi BC; Jiya JY
Am J Trop Med Hyg; 2009 May; 80(5):691-8. PubMed ID: 19407107
[TBL] [Abstract][Full Text] [Related]
10. Baseline Mapping of Neglected Tropical Diseases in Africa: The Accelerated WHO/AFRO Mapping Project.
Rebollo MP; Onyeze AN; Tiendrebeogo A; Senkwe MN; Impouma B; Ogoussan K; Zouré HGM; Deribe K; Cano J; Kinvi EB; Majewski A; Ottesen EA; Lammie P
Am J Trop Med Hyg; 2021 Apr; 104(6):2298-2304. PubMed ID: 33901001
[TBL] [Abstract][Full Text] [Related]
11. RRR for NNN-a rapid research response for the Neglected Tropical Disease NGDO Network: a novel framework to challenges faced by the global programs targeting neglected tropical diseases.
Toledo CE; Jacobson J; Wainwright EC; Ottesen EA; Lammie PJ
Int Health; 2016 Mar; 8 Suppl 1(Suppl 1):i12-4. PubMed ID: 26940303
[TBL] [Abstract][Full Text] [Related]
12. Implementation of mass drug administration for neglected tropical diseases in Guinea during the COVID-19 pandemic.
Sakho F; Badila CF; Dembele B; Diaby A; Camara AK; Lamah L; Reid SD; Weng A; Fuller BB; Sanchez KA; Kabore A; Zhang Y; Weaver A
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009807. PubMed ID: 34570807
[TBL] [Abstract][Full Text] [Related]
13. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
14. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
[TBL] [Abstract][Full Text] [Related]
15. Global programme to eliminate lymphatic filariasis: progress report, 2013.
Wkly Epidemiol Rec; 2014 Sep; 89(38):409-18. PubMed ID: 25243263
[No Abstract] [Full Text] [Related]
16. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
17. Neglected tropical diseases in Africa: a new paradigm.
Hopkins AD
Int Health; 2016 Mar; 8 Suppl 1():i28-33. PubMed ID: 26940307
[TBL] [Abstract][Full Text] [Related]
18. Ethiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases webs joined can tie a lion.
Mengitsu B; Shafi O; Kebede B; Kebede F; Worku DT; Herero M; French M; Kebede B; Mackenzie C; Martindale S; Kebede Z; Hirpa T; Frawley H; Crowley K; O'Neil M; McPherson S
Int Health; 2016 Mar; 8 Suppl 1():i34-52. PubMed ID: 26940308
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
Keating J; Yukich JO; Mollenkopf S; Tediosi F
Acta Trop; 2014 Jul; 135():86-95. PubMed ID: 24699086
[TBL] [Abstract][Full Text] [Related]
20. Intervention research on onchocerciasis and lymphatic filariasis.
Wkly Epidemiol Rec; 2000 Jul; 75(30):246-8. PubMed ID: 10946596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
